ROSWELL, Ga. & CLEVELAND--(BUSINESS WIRE)--CorMatrix® Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix® CanGaroo™ ECM® Envelope for use with cardiac implantable electronic devices (CIED’s) including pacemakers and implantable cardioverter defibrillators (ICD’s).
The CorMatrix® CanGaroo™ ECM® Envelope is intended to securely hold a cardiac implantable electronic device (CIED) in order to create a stable environment when implanted in the body. The CorMatrix® CanGaroo™ ECM® Envelope is a “pouch” which holds a CIED after implantation. It is constructed from a multi-laminate sheet of decellularized, non-crosslinked, lyophilized extracellular matrix (ECM®) derived from porcine small intestinal submucosa. The CorMatrix® CanGaroo™ ECM® Envelope will be provided in four sizes to fit an array of device types and sizes.
Help employers find you! Check out all the jobs and post your resume.
